A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism
Ali Ghaleiha(Hamedan University of Medical Sciences), Shahin Akhondzadeh(Arak University of Medical Sciences), Mohammadali Nikoo(Roozbeh Hospital), Mehdi Farokhnia(National Institutes of Health), Mohammad-Reza Mohammadi(Roozbeh Hospital), Soudeh Mohebbi Rasa(Tehran University of Medical Sciences)
Cited by 73
Related Papers
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151